IgG1-3 MuSK Antibodies Inhibit AChR Cluster Formation, Restored by SHP2 Inhibitor, Despite Normal MuSK, DOK7, or AChR Subunit Phosphorylation.
Cao M. et al, (2023), Neurol Neuroimmunol Neuroinflamm, 10
Motor end-plate analysis to diagnose immune-mediated myasthenia gravis in seronegative patients.
Nagaoka A. et al, (2022), J Neurol Sci, 443
Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis.
Damato V. et al, (2022), J Neurol Neurosurg Psychiatry, 93, 995 - 1000
Acute seizure risk in patients with encephalitis: development and validation of clinical prediction models from two independent prospective multicentre cohorts.
Wood GK. et al, (2022), BMJ Neurol Open, 4
Inhibition of Maternal-to-Fetal Transfer of IgG Antibodies by FcRn Blockade in a Mouse Model of Arthrogryposis Multiplex Congenita.
Coutinho E. et al, (2021), Neurol Neuroimmunol Neuroinflamm, 8
Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis.
Pollak TA. et al, (2021), Mol Psychiatry, 26, 2590 - 2604
Using AChR antibody titres to predict treatment responses in myasthenia gravis.
Vincent A., (2021), J Neurol Neurosurg Psychiatry
Neuronal surface antibodies are common in children with narcolepsy and active movement disorders.
Giannoccaro MP. et al, (2020), J Neurol Neurosurg Psychiatry
Myasthenia gravis AChR antibodies inhibit function of rapsyn-clustered AChRs.
Cetin H. et al, (2020), J Neurol Neurosurg Psychiatry
SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody.
Huda S. et al, (2020), Neurol Neuroimmunol Neuroinflamm, 7
Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia.
Vincent A. et al, (2018), JAMA Neurol, 75, 1519 - 1527
Investigation of neuronal auto-antibodies in children diagnosed with epileptic encephalopathy of unknown cause.
Tekturk P. et al, (2018), Brain Dev, 40, 909 - 917
Plasma cell depletion with bortezomib in the treatment of refractory N-methyl-d-aspartate (NMDA) receptor antibody encephalitis. Rational developments in neuroimmunological treatment.
Keddie S. et al, (2018), Eur J Neurol, 25, 1384 - 1388
NMDA-receptor antibodies alter cortical microcircuit dynamics.
Rosch RE. et al, (2018), Proc Natl Acad Sci U S A, 115, E9916 - E9925
Antiglycine receptor antibody related disease: a case series and literature review.
Swayne A. et al, (2018), Eur J Neurol, 25, 1290 - 1298
Passive Transfer of Human CASPR2 Antibodies into Mice Causes Behavioral and Neuropathological Changes
Giannoccaro MP. et al, (2018), ANNALS OF NEUROLOGY, 84, S137 - S137
SHP2 INHIBITION BY NSC-87877 RECOVERS THE PATHOGENIC IN VITRO EFFECTS OF MUSK-MG ANTIBODY SUBCLASSES
Cao M. et al, (2018), MUSCLE & NERVE, 58, S15 - S16
Glutamate receptor δ2 serum antibodies in pediatric opsoclonus myoclonus ataxia syndrome.
Berridge G. et al, (2018), Neurology, 91, e714 - e723
A passive transfer animal model of CASPR2 antibodies
Giannoccaro MP. et al, (2018), EUROPEAN JOURNAL OF NEUROLOGY, 25, 674 - 674
Brain-relevant antibodies in first-episode psychosis: a matched case-control study.
Gaughran F. et al, (2018), Psychol Med, 48, 1257 - 1263